At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
etafilcon A +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical and Laboratory Study of Lysozyme Deposition on Daily Disposable Contact Lenses
In Brief
A clinical study evaluating etafilcon A and nelfilcon A for Visual Acuity. Completed, enrolled 28 participants across 1 site.
Detailed Summary
In vitro studies show that some hydrogel materials uptake more lysozyme than other hydrogel materials and that this protein remains largely active and promotes reduced cytokine response in an in vitro culture of human corneal epithelial cells. This study investigates whether these data transfer to the in vivo situation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedFeb 2015
Primary CompletionJun 2015
TodayJul 2026
First PostedFeb 18, 2015
Enrollment StartJan 1, 2015
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.4 years ago
Interventions
etafilcon Adevice
etafilcon A soft contact lens
nelfilcon Adevice
nelfilcon A